Feinstein Institute Spin-off TheraSource Receives $3 Million NIH Grant to Develop a Mitigator for Nuclear Disasters

MANHASSET, NY – The Feinstein Institute for Medical Research  and TheraSource LLC , a Long Island-based biotech company, announced today that TheraSource has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The grant will support the development of human ghrelin as an innovative treatment to alleviate health damage caused by unintentional radiation exposure. The